Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,769
Total Claims
$1.6M
Drug Cost
651
Beneficiaries
$2,416
Cost/Patient
Risk Score Breakdown 64/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1731%
Opioid rate vs peers
69.3% vs 3.8% avg
+106%
Cost per patient vs peers
$2,416 vs $1,174 avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 1,731% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Composite risk score of 64/100 places this provider in the "High Risk" category — the top 0.017% of all Medicare Part D prescribers. Multiple independent risk factors are contributing simultaneously.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
69.3%
Opioid Rate
5,381
Opioid Claims
$1.2M
Opioid Cost
39.5%
Long-Acting Rate
This provider's opioid prescribing rate of 69.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 6,511 claims · $474K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 273 | $356K |
| Oxycodone Hcl | 357 | $332K |
| Oxycodone Hcl/Acetaminophen | 16 | $64K |
| Hydromorphone Hcl | 113 | $63K |
| Tapentadol Hcl | 48 | $61K |
| Oxycodone Hcl | 1,660 | $60K |
| Rimegepant Sulfate | 32 | $51K |
| Morphine Sulfate | 701 | $42K |
| Linaclotide | 60 | $42K |
| Fentanyl | 229 | $38K |
| Tapentadol Hcl | 32 | $35K |
| Oxymorphone Hcl | 54 | $34K |
| Erenumab-Aooe | 34 | $27K |
| Oxycodone Hcl/Acetaminophen | 511 | $26K |
| Buprenorphine Hcl | 28 | $24K |
Prescribing Profile
52
Unique Drugs
64.0
Anomaly Score
Patient Profile
65
Avg Age
63%
Female
1.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data